Neil Kumar, BridgeBio

Bridge­Bio spins gold out of an Alex­ion castoff, scor­ing an FDA ap­proval in rare me­tab­o­lism dis­or­der

Now part of the fold at As­traZeneca, rare dis­ease spe­cial­ist Alex­ion doesn’t miss of­ten when it comes to tak­ing meds across the fin­ish line. But …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.